Severe vinblastine-induced leukopenia during late pregnancy with delivery of a normal infant.
D000328:Adult; D000707:Anaphylaxis / Q000209:etiology; D000992:Antitoxins / Q000009:adverse effects; D003015:Clostridium Infections / Q000150:complications; D036861:Delivery, Obstetric; D005260:Female; D005333:Fetus / Q000187:drug effects*; D006689:Hodgkin Disease / Q000150:complications / Q000188:drug therapy; D006801:Humans; D007231:Infant, Newborn; D007970:Leukopenia / Q000139:chemically induced*; D010406:Penicillins / Q000627:therapeutic use; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy; D011250:Pregnancy Complications, Hematologic / Q000139:chemically induced*; D011251:Pregnancy Complications, Infectious; D011512:Proteus Infections / Q000150:complications; D011645:Puerperal Infection / Q000150:complications; D018805:Sepsis / Q000188:drug therapy; D013256:Steroids / Q000627:therapeutic use; D014747:Vinblastine / Q000009:adverse effects*
D000992:Antitoxins; D010406:Penicillins; D013256:Steroids; D014747:Vinblastine